Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

Recruiting

Phase 2

Phase 3

Biologic MedicationsUsing a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

Sponsor:

Wei-Che Ko

Code:

NCT05535738

Conditions

Skin Inflammation

Allergic Contact Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Squaric Acid Dibutyl Ester

Known patch test allergens

Dupilumab

Adalimumab

Ustekinumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-30. This information was provided to ClinicalTrials.gov by Wei-Che Ko on 2025-11-14.